Allegrow Biotech is revolutionizing cell manufacturing with a proprietary platform that enables cost-effective, high-volume production of therapeutic cells. Their hydrogel microparticles and biomimetic coatings create an optimal environment for generating therapeutic cells, such as tumour-killing cytotoxic T cells, potentially accelerating access to life-saving cell therapies for patients.
|Cohorts||Biotech & Life Science|
|Fundraising Stage||Series Seed|
|Region||Hong Kong SAR|